Developmental timing of exposure to elevated levels of phenylalanine is associated with ADHD symptom expression

Kevin M Antshel1, Susan E Waisbren

  • 1Children's Hospital-Boston, Division of Psychology, Department of Psychiatry, Harvard Medical School, Longwood Avenue, Boston, Massachusetts, USA. antshelk@upstate.edu

Insights

Timing of phenylalanine exposure impacts attention deficit hyperactivity disorder (ADHD) symptoms. Prenatal exposure links to hyperactivity/impulsivity, while postnatal exposure is associated with inattentive symptoms in children with Phenylketonuria (PKU) and Maternal PKU (MPKU).

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Metabolic Disorders

Background:

  • Attention deficit hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder.
  • Elevated phenylalanine levels are a known biological insult.
  • The timing of exposure to biological insults may influence neurodevelopmental outcomes.

Purpose of the Study:

  • To investigate the association between the timing of elevated phenylalanine exposure and ADHD symptom presentation.
  • To compare ADHD symptom profiles in children with Phenylketonuria (PKU) and Maternal PKU (MPKU).
  • To examine the dose-dependent effects of phenylalanine on ADHD symptoms.

Main Methods:

  • Comparative study design.
  • Inclusion of children with Phenylketonuria (PKU) (postnatal exposure) and Maternal PKU (MPKU) (prenatal exposure).
  • Inclusion of non-hyperphenylalaninemic siblings as controls.

Main Results:

  • Elevated phenylalanine levels are associated with ADHD symptoms.
  • Prenatal phenylalanine exposure (MPKU) is linked to a higher likelihood of hyperactive/impulsive symptoms.
  • Postnatal phenylalanine exposure (PKU) is linked to a higher likelihood of inattentive symptoms.
  • Phenylalanine toxicity is dose-dependent, with higher levels being more detrimental.

Conclusions:

  • The timing of phenylalanine exposure significantly influences the manifestation of ADHD symptoms.
  • Prenatal and postnatal phenylalanine exposure present distinct ADHD symptom profiles.
  • Management of phenylalanine levels is crucial for mitigating neurodevelopmental risks associated with ADHD.

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...